BWA
USNA icon

Basecamp Wealth Advisors’s Usana Health Sciences USNA Stock Holding History

Basecamp Wealth Advisors’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$897 Buy
42
+7
+20% +$132 ﹤0.01% 1536
2026
Q1 		$611 Buy
+35
New +$695 ﹤0.01% 1672

Other funds holding USNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Basecamp Wealth Advisors's USNA Position: Q2 2026 in Review

Basecamp Wealth Advisors increased its Usana Health Sciences (USNA) stake by 20% in Q2 2026, buying an estimated $132 and bringing the position to 42 shares worth $897. The position accounts for ﹤0.01% of the portfolio, ranked #1536.

Basecamp Wealth Advisors first reported a position in USNA in Q1 2026 and has held it in 2 quarters since. 138 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

  • Basecamp Wealth Advisors held 42 shares of Usana Health Sciences worth $897 as of Q2 2026.
  • Basecamp Wealth Advisors bought 7 Usana Health Sciences shares in Q2 2026, an estimated $132.
  • Usana Health Sciences made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #1536 holding.
  • Basecamp Wealth Advisors first reported a position in Usana Health Sciences in Q1 2026 and has held it in 2 quarters since.
  • 138 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.